Clinical and Pharmacologic Differences of CDK4/6 Inhibitors in Breast Cancer

por George, Mridula A., Qureshi, Sadaf, Omene, Coral, Toppmeyer, Deborah L., Ganesan, Shridar
Publicado 2021

Immune Checkpoint Inhibitors in Triple Negative Breast Cancer: The Search for the Optimal Biomarker

por Qureshi, Sadaf, Chan, Nancy, George, Mridula, Ganesan, Shridar, Toppmeyer, Deborah, Omene, Coral
Publicado 2022

Patterns of postmastectomy radiation therapy in clinically node-positive breast cancer patients with pathologically negative lymph nodes after neoadjuvant chemotherapy

por SAYAN, Mutlay, VERGALASOVA, Irina, GEORGE, Mridula, KOWZUN, Maria, POTDEVIN, Lindsay, KUMAR, Shicha, HAFFTY, Bruce, OHRI, Nisha
Publicado 2021

Reconstructive complications and early toxicity in breast cancer patients treated with proton-based postmastectomy radiation therapy

por Sayan, Mutlay, Hathout, Lara, Kilic, Sarah S., Jan, Imraan, Gilles, Ambroise, Hassell, Natalie, Kowzun, Maria, George, Mridula, Potdevin, Lindsay, Kumar, Shicha, Sinkin, Jeremy, Agag, Richard, Haffty, Bruce G., Ohri, Nisha
Publicado 2023